1. Lee KM, Woo SJ, Hwang JM. Morphologic characteristics of optic nerve head drusen on spectral-domain optical coherence tomography. Am J Ophthalmol. 2013; 155:1139–47.
Article
2. Lee KM, Woo SJ, Hwang JM. Differentiation of optic nerve head drusen and optic disc edema with spectral-domain optical coherence tomography. Ophthalmology. 2011; 118:971–7.
Article
3. Neffendorf JE, Mulholland C, Quinlan M, Lyons CJ. Disc drusen complicated by optic disc hemorrhage in childhood. Can J Ophthalmol. 2010; 45:537–8.
Article
4. Auw-Haedrich C, Staubach F, Witschel H. Optic disk drusen. Surv Ophthalmol. 2002; 47:515–32.
Article
5. Sanders TE, Gay AJ, Newman M. Hemorrhagic complications of drusen of the optic disk. Am J Ophthalmol. 1971; 71:204–17.
Article
6. Mullie MA, Sanders MD. Scleral canal size and optic nerve head drusen. Am J Ophthalmol. 1985; 99:356–9.
Article
7. Harris MJ, Fine SL, Owens SL. Hemorrhagic complications of optic nerve drusen. Am J Ophthmol. 1981; 92:70–6.
Article
8. Johnson LN, Diehl ML, Hamm CW, et al. Differentiating optic disc edema from optic nerve head drusen on optical coherence tomography. Arch Ophthalmol. 2009; 127:45–9.
Article
9. Grippo TM, Shihadeh WA, Schargus M, et al. Optic nerve head drusen and visual field loss in normotensive and hypertensive eyes. J Glaucoma. 2008; 17:100–4.
Article
10. Chaudhry NA, Lavaque AJ, Shah A, Liggett PE. Photodynamic therapy for choroidal neovascular memebrane secondary to optic nerve drusen. Ophthalmic Surg Lasers Imaging. 2005; 36:70–2.
11. Knape RM, Zavaleta EM, Clark CL 3rd, et al. Intravitreal bevacizumab treatment of bilateral peripapillary choroidal neo- vascularization from optic nerve head drusen. J AAPOS. 2011; 15:87–90.